Germline genetic testing services
Ended Purchase Order Awarded Last action
- Contract number
- 36C10X22P0119
- Awardee
-
Fulgent Therapeutics LLC UEI JVZDRESJLD82 Part of Fulgent Genetics, Inc.
- Awarding agency
-
VA Strategic Acquisition Center Frederick
Headquarters, Department of Veterans Affairs
- Obligated
- $4,339,202
Award facts
- Opportunity
-
- Q301--Germline Genetic Lab Testing Services_VHA_National Oncology Program Pre-Solicitation · 36C10X22Q0164 · Posted May 26, 2022
- Contract value 100% obligated
- $4,339,202.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 6 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Temple City, CA 91780, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$1,903,589 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$47,348 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,204,514 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $30,000 | |
| Exercise an Option | $2,000,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,055,625 |
Show all 12
About this award
Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, received a $4.34 million firm fixed price purchase order from the Department of Veterans Affairs Strategic Acquisition Center Frederick on September 27, 2022, for germline genetic testing services. The contract will be performed in Temple City, California, and is scheduled for completion by September 26, 2025. This award was issued without a set-aside designation, indicating open competition. The purchase order supports the VA's National Oncology Program by providing comprehensive reference laboratory testing services, including mandatory multi-gene panels and next-generation sequencing for genetic screening across multiple medical specialties including oncology, cardiovascular disease, gastrointestinal conditions, neurological disorders, and various other therapeutic areas.
This procurement derives from a broader VA initiative to establish centralized germline genetic testing capabilities across the Veterans Health Administration enterprise. The award is associated with the VA Strategic Acquisition Center's larger indefinite delivery contract vehicle valued at approximately $99 million, which provides national access to germline genetic testing across oncology, medical genetics, and pharmacogenomics programs. Fulgent Therapeutics, a subsidiary of Fulgent Genetics, Inc., has demonstrated substantial capacity to service federal healthcare systems through multiple contract awards with the VA, Department of Defense, and other federal agencies. The contractor's offerings include consultation services, result interpretation, and next-generation sequencing technology across multiple medical domains, supporting the VA's commitment to providing advanced genetic diagnostic capabilities to veterans nationwide.
Quick answers
Who was awarded contract 36C10X22P0119?
36C10X22P0119 was awarded to Fulgent Therapeutics LLC by VA Strategic Acquisition Center Frederick (Headquarters) on September 27, 2022.
How much is contract 36C10X22P0119 worth?
The government has obligated $4,339,202 on 36C10X22P0119.
Was contract 36C10X22P0119 competed?
The extent of competition for 36C10X22P0119 was competed under sap. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award